Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Baseline immune dysregulation in autologous stem cell transplant recipients is associated with a 'graft versus host'-like syndrome and poor outcomes.
Anagnostou T, Sakemura R, Forsman CL, Patnaik MS, Paludo J, Gastineau DA, Buadi FK, Porrata LF, Kumar SK, Gertz MA, Lacy MQ, Dispenzieri A, Gonsalves WI, Lehman JS, Hogan WJ, Hashmi SK, Alkhateeb H, Shah MV, Litzow MR, Kenderian SS. Anagnostou T, et al. Among authors: shah mv. Bone Marrow Transplant. 2020 Sep;55(9):1879-1881. doi: 10.1038/s41409-020-0851-3. Epub 2020 Mar 11. Bone Marrow Transplant. 2020. PMID: 32161319 No abstract available.
Characteristics of late transplant-associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
Heybeli C, Sridharan M, Alkhateeb HB, Villasboas Bisneto JC, Buadi FK, Chen D, Dingli D, Dispenzieri A, Gertz MA, Go RS, Hashmi SK, Hayman SR, Hogan WJ, Inwards DJ, Kenderian SS, Kumar SK, Litzow MR, Porrata LF, Lacy MQ, Micallef IN, Patnaik MM, Shah MV, Leung N. Heybeli C, et al. Among authors: shah mv. Am J Hematol. 2020 Oct;95(10):1170-1179. doi: 10.1002/ajh.25922. Epub 2020 Aug 8. Am J Hematol. 2020. PMID: 32618000 Free article.
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.
Hampel PJ, Parikh SA, Call TG, Shah MV, Bennani NN, Al-Kali A, Rabe KG, Wang Y, Muchtar E, Leis JF, Kenderian SS, Koehler AB, Schwager SM, Slager SL, Kay NE, Hanson CA, Van Dyke DL, Shi M, Ding W. Hampel PJ, et al. Among authors: shah mv. Blood Cancer J. 2021 Mar 2;11(3):47. doi: 10.1038/s41408-021-00443-1. Blood Cancer J. 2021. PMID: 33654067 Free PMC article. No abstract available.
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.
Joshi M, Cook J, McCullough K, Nanaa A, Gangat N, Foran JM, Murthy HS, Kharfan-Dabaja MA, Sproat L, Palmer J, Pardanani A, Tefferi A, Begna K, Elliot M, Al-Kali A, Patnaik M, Shah MV, Hogan WJ, Litzow MR, Alkhateeb HB. Joshi M, et al. Among authors: shah mv. Blood Cancer J. 2021 Mar 4;11(3):49. doi: 10.1038/s41408-021-00437-z. Blood Cancer J. 2021. PMID: 33664234 Free PMC article. No abstract available.
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).
Saw JL, Sidiqi MH, Ruff M, Hocker S, Alkhateeb H, Ansell SM, Bennani NN, Dingli D, Hayman SR, Johnston PB, Kapoor P, Kenderian SJ, Kourelis TV, Kumar SK, Paludo J, Shah MV, Siddiqui MA, Warsame R, Rosenthal A, Grill M, Castro JE, Siegel J, Abdel Rahman ZH, Kharfan-Dabaja MA, So E, Lin Y. Saw JL, et al. Among authors: shah mv. Blood Cancer J. 2022 Apr 13;12(4):62. doi: 10.1038/s41408-022-00657-x. Blood Cancer J. 2022. PMID: 35418113 Free PMC article. No abstract available.
Outcomes following venetoclax-based treatment in therapy-related myeloid neoplasms.
Shah MV, Chhetri R, Dholakia R, Kok CH, Gangat N, Alkhateeb HB, Al-Kali A, Patnaik MM, Baranwal A, Greipp PT, He R, Begna KH, Tiong IS, Wei AH, Hiwase D. Shah MV, et al. Am J Hematol. 2022 Aug;97(8):1013-1022. doi: 10.1002/ajh.26589. Epub 2022 May 27. Am J Hematol. 2022. PMID: 35560061 Free PMC article.
Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs.
Ghorab A, Al-Kali A, Elliot M, Gangat N, Alkhateeb H, Shah M, Liu Y, Yi CA, Murthy H, Kharfan-Dabaja M, Tefferi A, Patnaik M, Litzow M, Badar T. Ghorab A, et al. Blood Cancer J. 2022 Jun 24;12(6):93. doi: 10.1038/s41408-022-00691-9. Blood Cancer J. 2022. PMID: 35750664 Free PMC article. No abstract available.
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
Zanwar S, Abeykoon JP, Dasari S, Ravindran A, Young JR, Acosta-Medina AA, Rech KL, Schwartz J, Mangold A, Rosenthal A, Bennani NN, Shah MV, Morlote D, Goyal G, Go RS. Zanwar S, et al. Among authors: shah mv. Blood Cancer J. 2022 Jun 28;12(6):97. doi: 10.1038/s41408-022-00693-7. Blood Cancer J. 2022. PMID: 35764604 Free PMC article. No abstract available.
234 results